Deerfield Management Company, L.P. (Series C) Edgewise Therapeutics, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $3.95 Billion
- Q1 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 2,078,509 shares of EWTX stock, worth $29 Million. This represents 1.16% of its overall portfolio holdings.
Number of Shares
2,078,509
Previous 2,078,509
-0.0%
Holding current value
$29 Million
Previous $55.5 Million
17.6%
% of portfolio
1.16%
Previous 1.37%
Shares
4 transactions
Others Institutions Holding EWTX
# of Institutions
220Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$210 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$124 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$91.3 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$85.9 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$83.9 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $881M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...